Literature DB >> 19144044

Bioterrorism for the respiratory physician.

Grant W Waterer1, Hannah Robertson.   

Abstract

Terrorist attacks by definition are designed to cause fear and panic. There is no question that a terrorist attack using biological agents would present a grave threat to stability of the society in which they were released. Early recognition of such a bioterrorist attack is crucial to containing the damage they could cause. As many of the most likely bioterrorism agents present with pulmonary disease, respiratory physicians may be crucial in the initial recognition and diagnosis phase, and certainly would be drawn into treatment of affected individuals. This review focuses on the biological agents thought most likely to be used by terrorists that have predominantly respiratory presentations. The primary focus of this review is on anthrax, plague, tularaemia, ricin, and Staphylococcal enterotoxin B. The pathogenesis, clinical manifestations and treatment of these agents will be discussed as well as historical examples of their use. Other potential bioterrorism agents with respiratory manifestations will also be discussed briefly.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19144044     DOI: 10.1111/j.1440-1843.2008.01446.x

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  4 in total

1.  Drug interactions with Bacillus anthracis topoisomerase IV: biochemical basis for quinolone action and resistance.

Authors:  Katie J Aldred; Sylvia A McPherson; Pengfei Wang; Robert J Kerns; David E Graves; Charles L Turnbough; Neil Osheroff
Journal:  Biochemistry       Date:  2011-12-16       Impact factor: 3.162

2.  Prioritizing risks and uncertainties from intentional release of selected Category A pathogens.

Authors:  Tao Hong; Patrick L Gurian; Yin Huang; Charles N Haas
Journal:  PLoS One       Date:  2012-03-06       Impact factor: 3.240

3.  Interactions between Quinolones and Bacillus anthracis Gyrase and the Basis of Drug Resistance.

Authors:  Rachel E Ashley; R Hunter Lindsey; Sylvia A McPherson; Charles L Turnbough; Robert J Kerns; Neil Osheroff
Journal:  Biochemistry       Date:  2017-08-01       Impact factor: 3.162

Review 4.  Respiratory infections: a current and future threat.

Authors:  Grant Waterer; Richard Wunderink
Journal:  Respirology       Date:  2009-07       Impact factor: 6.424

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.